Natural Language Processing (NLP) In Healthcare And Life Sciences Market Report 2026

Natural Language Processing (NLP) In Healthcare And Life Sciences Market Overview

• Natural Language Processing (NLP) In Healthcare And Life Sciences market size has reached to $3.7 billion in 2025 • Expected to grow to $10.99 billion in 2030 at a compound annual growth rate (CAGR) of 24.4% • Growth Driver: Personalized Medicine Driving NLP Growth In Healthcare • Market Trend: Major Companies Drive NLP Advancements In Life Sciences • North America was the largest region in 2025.

What Is Covered Under Natural Language Processing (NLP) In Healthcare And Life Sciences Market?

Natural language processing (NLP) in healthcare and life sciences refers to a field of Artificial Intelligence (AI) that enables machines to comprehend and communicate in human speech. It is used to discover data patterns and perform automated healthcare and life sciences tasks. The main types of NLP in healthcare and life sciences are rule-based NLP, statistical NLP, and hybrid NLP. Rule-based NLP, also known as rule-based natural language processing, is an approach to processing and understanding human language using predefined rules and patterns. The various components are solutions, and services used in large enterprises, and small and midsize enterprises (SMEs). The various applications are sentiment analysis, drug discovery, clinical trial matching, risk and compliance management, dictation and EMR implication, automated registry reporting, AI chatbots and virtual scribe, and others used by public health and government agencies, medical devices, healthcare insurance, pharmaceuticals, and others.

What Is The Natural Language Processing (NLP) In Healthcare And Life Sciences Market Growth Forecast?

The natural language processing (nlp) in healthcare and life sciences market size is expected to see exponential growth in the next few years. It will grow to $10.99 billion in 2030 at a compound annual growth rate (CAGR) of 24.4%. The growth in the forecast period can be attributed to AI integration in clinical workflows, precision medicine adoption, healthcare automation demand, cloud based healthcare platforms, shortage of medical professionals. Major trends in the forecast period include clinical text analytics, automated medical coding, AI driven drug discovery, virtual health assistants, real time clinical decision support.

Global Natural Language Processing (NLP) In Healthcare And Life Sciences Market Segmentation

1) By NLP Type: Rule-Based NLP, Statistical NLP, Hybrid NLP 2) By Component: Solutions, Services 3) By Organization Size: Large Enterprises, Small And Midsize Enterprises (SMEs) 4) By Application: Sentiment Analysis, Drug Discovery, Clinical Trail Matching, Risk And Compliance Management, Dictation And EMR Implication, Automated Registry Reporting, AI Chatbots And Virtual Scribe, Other Applications 5) By End-User: Public Health And Government Agencies, Medical Devices, Healthcare Insurance, Pharmaceuticals, Other End-Users Subsegments: 1) By Rule-Based NLP: Expert Systems, Knowledge-Based Approaches, Grammar-Based NLP 2) By Statistical NLP: Machine Learning Models, Natural Language Understanding (NLU), Text Classification And Clustering 3) By Hybrid NLP: Combining Rule-Based And Statistical Approaches, Context-Aware NLP, Deep Learning Models

What Is The Driver Of The Natural Language Processing (NLP) In Healthcare And Life Sciences Market?

The growing demand for personalized medicine is driving the growth of NLP in the healthcare and life sciences market. Personalized medicine tailors medical treatment to an individual's unique characteristics, such as genetic makeup or lifestyle, for more effective and precise healthcare outcomes. Leveraging Natural Language Processing (NLP) in the healthcare and life sciences market facilitates the extraction and analysis of vast amounts of patient data, contributing to the growing demand for personalized medicine by enabling insights into individualized health profiles and treatment strategies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the USFDA approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from 6 personalized treatments in 2022. Therefore, the growing demand for personalized medicine is expected to propel the growth of NLP in the healthcare and life sciences market.

Key Players In The Global Natural Language Processing (NLP) In Healthcare And Life Sciences Market

Major companies operating in the natural language processing (nlp) in healthcare and life sciences market are Google LLC; Microsoft Corporation; Optum Inc.; Amazon Web Services Inc.; International Business Machines Corporation; 3M Company; IQVIA Holdings Inc.; Cerner Corporation; Inovalon Holdings Inc.; NextGen Healthcare Inc.; Welltok Inc.; HealthFusion Inc.; Syapse Inc.; Apixio Inc.; Infermedica; Health Fidelity Inc.; Linguamatics Ltd.; Dolbey Systems Inc.; Lexalytics Inc.; Clinithink Ltd.; Semedy AG; Zyla Health; Anumana Inc.; Averbis GmbH; Pera Health; Notable Health; Olive AI; Olive Inc.; Epic Systems Corporation

Global Natural Language Processing (NLP) In Healthcare And Life Sciences Market Trends and Insights

Major companies operating in the NLP in the healthcare and life sciences market are focusing on product launches, such as Generative AI-Powered Service, to automatically create preliminary clinical documentation from patient-clinician conversations. A generative AI-powered service is a technology that utilizes artificial intelligence to autonomously create, generate, or produce content, solutions, or outcomes based on learned patterns and data inputs. For instance, in July 2023, Amazon Web Services (AWS), a US-based company that offers cloud computing services and APIs to individuals, businesses, and governments, launched AWS HealthScribe, a new generative AI-powered service that automatically creates clinical documentation. This launch leverages speech recognition and generative AI to automatically identify speaker roles, classify dialogues, extract medical terms, and generate rich preliminary clinical transcripts, thereby streamlining documentation processes and enhancing the efficiency of NLP applications in the healthcare and life sciences market. By providing HIPAA-compliant automation of clinical documentation, AWS HealthScribe not only reduces documentation time for healthcare professionals but also improves the overall quality of healthcare services through enhanced workflow efficiency and patient engagement.

What Are Latest Mergers And Acquisitions In The Natural Language Processing (NLP) In Healthcare And Life Sciences Market?

In May 2023, Intelligent Medical Objects, a U.S.-based provider of clinical terminology management, data quality, and healthcare data enablement solutions, acquired Melax Technologies, Inc. for an undisclosed amount. With this acquisition, Intelligent Medical Objects aims to accelerate its natural language processing (NLP)-driven analytics and business intelligence offerings for healthcare organizations, thereby expanding its addressable market in clinical and financial performance optimization. Melax Technologies is a U.S.-based provider of healthcare data analytics and business intelligence services focused on leveraging NLP to extract insights from biomedical text and unstructured clinical information.

Regional Insights

North America was the largest region in the NLP in healthcare and life sciences market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Natural Language Processing (NLP) In Healthcare And Life Sciences Market?

The NLP in healthcare and life sciences market consists of revenues earned by entities by providing information extraction, streamline workflows, improve predictive analytics, and clinical decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The NLP in healthcare and life sciences market also includes sales of medical coder and EHRs (electronic health records). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Natural Language Processing (NLP) In Healthcare And Life Sciences Market Report 2026?

The natural language processing (nlp) in healthcare and life sciences market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the natural language processing (nlp) in healthcare and life sciences industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.